Aerie Pharmaceuticals
- Biological Products, Except Diagnostic Substances
- Durham, North Carolina
Compensation history
Top executives at Aerie Pharmaceuticals received an average of $3M per person in annual compensation from 2012 to 2021.
Average pay of disclosed executives at Aerie Pharmaceuticals
By year
- 2021
VA$4MVicente Anido, Jr.Former Chief Executive Officer and Chairman of the BoardRK$4MRaj KannanChief Executive Officer and DirectorTM$2MThomas A. MitroFormer President and Chief Operating OfficerCK$1MCasey C. KopczynskiChief Innovation Officer, Head of Research and External InnovationJL$1MJohn W. LaRoccaGeneral Counsel and SecretaryBM$1MBenjamin F. McGraw, IIIFormer Interim Executive ChairRR$1MRichard J. RubinoFormer Chief Financial Officer, Secretary and TreasurerCS$532KChristopher StatenFormer Interim Chief Financial Officer- 2020
VA$4MVicente Anido, Jr.Chief Executive Officer and Chairman of the BoardTM$2MThomas A. MitroPresident and Chief Operating OfficerRR$2MRichard J. RubinoChief Financial Officer, Secretary and TreasurerCK$1MCasey C. KopczynskiChief Scientific OfficerJL$945KJohn W. LaRoccaGeneral Counsel and Assistant SecretaryDH$649KDavid A. HollanderChief Research and Development Officer- 2019
VA$6MVicente Anido, Jr.Chief Executive Officer and Chairman of the BoardTM$3MThomas A. MitroPresident and Chief Operating OfficerJL$3MJohn W. LaRoccaGeneral Counsel and Assistant SecretaryRR$2MRichard J. RubinoChief Financial Officer, Secretary and TreasurerDH$2MDavid A. HollanderChief Research and Development OfficerCK$2MCasey C. KopczynskiChief Scientific Officer
Executives
We found 11 executives who work or worked at Aerie Pharmaceuticals.
Raj Kannan
Aerie Pharmaceuticals
Chief Executive Officer
Casey Kopczynski
Aerie Pharmaceuticals
Chief Innovation Officer, Head of Research and External Innovation
John LaRocca
Aerie Pharmaceuticals
General Counsel
Benjamin McGraw
Aerie Pharmaceuticals
Former Interim Executive Chair
Thomas Mitro
Aerie Pharmaceuticals
Chief Operating Officer
Vicente Anido
Aerie Pharmaceuticals
Chief Executive Officer
Richard Rubino
Aerie Pharmaceuticals
Chief Financial Officer
Christopher Staten
Aerie Pharmaceuticals
Chief Financial Officer
News
Aerie Pharmaceuticals CEO Vicente Anido's 2021 pay rises 4% to $3.8M
April 26, 2022
Aerie Pharmaceuticals CEO Vicente Anido's 2020 pay falls 35% to $3.6M
April 27, 2021
Aerie Pharmaceuticals CEO Vicente Anido's 2019 pay slips 18% to $5.5M
April 24, 2020
Aerie Pharmaceuticals CEO Vicente Anido's 2018 pay falls 33% to $6.8M
April 10, 2019
About Aerie Pharmaceuticals
- Industry classifications
- DivisionManufacturing
- Major groupChemicals And Allied Products
- Industry groupDrugs
- IndustryBiological Products, Except Diagnostic Substances
- Address4301 Emperor Boulevard, Suite 400, Durham, North Carolina 27703
- Phone(919) 237-5300
- Fiscal year endDecember 31
Source: SEC filings on April 26, 2022, April 27, 2021, April 24, 2020, April 10, 2019, April 27, 2018, April 27, 2017, April 29, 2016, February 27, 2015, and April 30, 2014.